Cite

HARVARD Citation

    Choi, D. et al. (2023). Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease. Annals of pharmacotherapy. 57 (5), pp. 579-584. [Online]. 
  
Back to record